blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2612858

EP2612858 - STAT3/5 activation inhibitor [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.07.2014
Database last updated on 24.08.2024
Most recent event   Tooltip25.07.2014Application deemed to be withdrawnpublished on 27.08.2014  [2014/35]
Applicant(s)For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kanda Tsukasamachi 2-chome Chiyoda-ku
Tokyo 101-8535 / JP
[2013/28]
Inventor(s)01 / Sekiguchi, Kazuo
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
02 / Suzuki, Takashi
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
03 / Ohbuchi, Yutaka
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
04 / Okuno, Mitsuhiro
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
05 / Ohi, Naoto
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
06 / Ohnishi, Kenji
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
07 / Motoyama, Masaaki
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
08 / Yoshida, Kenji
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
09 / Kodama, Takeshi
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
10 / Sugiyama, Kazuhisa
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
11 / Akamatsu, Seiji
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
12 / Kiyono, Kunihiko
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
13 / Yanagihara, Yasuo
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
14 / Watanabe, Takashi
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
15 / Hayashi, Kazuhiko
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
16 / Tanaka, Hideo
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
17 / Sumida, Takumi
c/o OTSUKA PHARMACEUTICAL CO., LTD.
11-1, Karasaki 1-chome
Otsu-shi
Shiga, 520-0106 / JP
 [2013/28]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2013/28]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date13153028.902.10.2007
[2013/28]
Priority number, dateJP2006027117202.10.2006         Original published format: JP 2006271172
[2013/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2612858
Date:10.07.2013
Language:EN
[2013/28]
Search report(s)(Supplementary) European search report - dispatched on:EP07.06.2013
ClassificationIPC:C07D317/58, C07D405/12
[2013/28]
CPC:
C07D401/12 (EP,US); C07D317/58 (KR); A61P15/14 (EP);
A61P17/06 (EP); A61P25/00 (EP); A61P25/28 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/06 (EP); C07D213/38 (EP,US); C07D401/04 (EP,US);
C07D405/12 (EP,KR,US); C07D405/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/28]
Extension statesHR29.01.2013
TitleGerman:STAT3/5-Aktivierungshemmer[2013/28]
English:STAT3/5 activation inhibitor[2013/28]
French:Inhibiteur d'activation de la stat3/5[2013/28]
Examination procedure29.01.2013Examination requested  [2013/28]
11.01.2014Application deemed to be withdrawn, date of legal effect  [2014/35]
24.02.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/35]
Parent application(s)   TooltipEP07829383.4  / EP2089373
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070829383) is  31.07.2009
Fees paidRenewal fee
29.01.2013Renewal fee patent year 03
29.01.2013Renewal fee patent year 04
29.01.2013Renewal fee patent year 05
29.01.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.10.201307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]WO2006014012  (OTSUKA PHARMA CO LTD [JP], et al) [XD] 1-8 * page 675; example 582 * * page 726; example 1039 * * page 655; example 322 * * page 779; example 1503 * * page 716; example 940 * * page 864; example 2228 * * page 754; example 1202 * * page 4, line 3 * * page 1, line 7 - line 9 * * page 729; example 1049 *;
 [XP]WO2007066784  (OTSUKA PHARMA CO LTD [JP], et al) [XP] 1-8 * page 428, line 16 - line 28 ** page 1014; claim 1 *
by applicantUS2001029250
 WO2006014012
    - J.GERONTOLOGY; MEDICAL SCIENCES, (2006), vol. 61A, no. 6, pages 575 - 584
    - J. EXP. MED., (2002), vol. 196, no. 5, pages 641 - 653
    - NATURE MEDICINE, (2005), vol. 11, no. 1, pages 43 - 49
    - PNAS, (20040330), vol. 101, no. 13, pages 4661 - 4666
    - J. IMMUNOLOGY, (2006), vol. 177, pages 3421 - 3426
    - ANN. RHEUM. DIS., (2004), vol. 63, pages 67 - 71
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.